Short Interest in iRhythm Technologies, Inc. (NASDAQ:IRTC) Expands By 8.7%

iRhythm Technologies, Inc. (NASDAQ:IRTC - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,740,000 shares, an increase of 8.7% from the October 15th total of 2,520,000 shares. Based on an average daily trading volume, of 602,100 shares, the short-interest ratio is currently 4.6 days.

Insider Activity at iRhythm Technologies

In related news, CEO Quentin S. Blackford sold 16,145 shares of the business's stock in a transaction on Monday, November 4th. The shares were sold at an average price of $77.41, for a total value of $1,249,784.45. Following the transaction, the chief executive officer now owns 159,929 shares in the company, valued at $12,380,103.89. The trade was a 9.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Abhijit Y. Talwalkar acquired 6,664 shares of the company's stock in a transaction dated Monday, November 4th. The shares were bought at an average price of $75.16 per share, for a total transaction of $500,866.24. Following the acquisition, the director now directly owns 18,941 shares of the company's stock, valued at approximately $1,423,605.56. This trade represents a 54.28 % increase in their position. The disclosure for this purchase can be found here. 0.68% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC grew its position in shares of iRhythm Technologies by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 733,308 shares of the company's stock valued at $54,451,000 after acquiring an additional 5,423 shares during the period. Brophy Wealth Management LLC purchased a new stake in shares of iRhythm Technologies during the 3rd quarter valued at approximately $274,000. Barclays PLC lifted its stake in shares of iRhythm Technologies by 34.3% during the 3rd quarter. Barclays PLC now owns 209,247 shares of the company's stock valued at $15,534,000 after buying an additional 53,498 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of iRhythm Technologies by 6.2% during the 3rd quarter. Wellington Management Group LLP now owns 213,949 shares of the company's stock valued at $15,884,000 after buying an additional 12,478 shares in the last quarter. Finally, Western Standard LLC purchased a new stake in shares of iRhythm Technologies during the 3rd quarter valued at approximately $4,535,000.

iRhythm Technologies Stock Down 3.6 %

IRTC stock traded down $2.99 during trading on Friday, reaching $80.45. The stock had a trading volume of 480,421 shares, compared to its average volume of 719,896. iRhythm Technologies has a one year low of $55.92 and a one year high of $124.11. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00. The company's 50 day moving average is $72.65 and its two-hundred day moving average is $83.00. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of -16.55 and a beta of 1.23.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.71). iRhythm Technologies had a negative return on equity of 120.86% and a negative net margin of 26.90%. The firm had revenue of $147.54 million during the quarter, compared to the consensus estimate of $146.69 million. During the same period in the previous year, the company posted ($0.89) earnings per share. The company's revenue for the quarter was up 18.4% on a year-over-year basis. Equities research analysts forecast that iRhythm Technologies will post -3.44 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on IRTC shares. Needham & Company LLC dropped their price objective on shares of iRhythm Technologies from $119.00 to $96.00 and set a "buy" rating on the stock in a report on Thursday, October 31st. StockNews.com lowered shares of iRhythm Technologies from a "hold" rating to a "sell" rating in a report on Friday, September 27th. JPMorgan Chase & Co. lowered their target price on shares of iRhythm Technologies from $133.00 to $100.00 and set an "overweight" rating on the stock in a report on Friday, August 2nd. The Goldman Sachs Group started coverage on shares of iRhythm Technologies in a report on Friday, October 4th. They issued a "neutral" rating and a $78.00 target price on the stock. Finally, Canaccord Genuity Group upped their target price on shares of iRhythm Technologies from $122.00 to $137.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $108.50.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.